-
(2006)
EVAN Study Group
-
A.
Vila-Córcoles,
O.
Ochoa-Gondar,
I.
Hospital,
Xabier
Ansa,
Angels
Vilanova,
T.
Rodríguez,
C.
Llor
(2006)
Protective effects of the 23-valent pneumococcal polysaccharide vaccine in the elderly population: the EVAN-65 study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 43 7
-
N.
Pelletier,
L.
McHeyzer-Williams,
Kurt
Wong,
E.
Urich,
N.
Fazilleau,
M.
McHeyzer-Williams
(2010)
Plasma cells negatively regulate the follicular helper T cell program
Nature immunology, 11
-
K.
Klugman,
S.
Madhi,
C.
Feldman
(2007)
HIV and pneumococcal disease
Current Opinion in Infectious Diseases, 20
-
N.
Bisharat,
H.
Omari,
I.
Lavi,
R.
Raz
(2001)
Risk of infection and death among post-splenectomy patients.
The Journal of infection, 43 3
-
J.
Nuorti,
C.
Whitney
(2010)
Updated recommendations for prevention of invasive pneumococcal disease among adults using the 23-valent pneumococcal polysaccharide vaccine (PPSV23).
MMWR. Morbidity and mortality weekly report, 59 34
-
K.
O'Brien,
M.
Hochman,
D.
Goldblatt
(2007)
Combined schedules of pneumococcal conjugate and polysaccharide vaccines: is hyporesponsiveness an issue?
The Lancet. Infectious diseases, 7 9
-
N.
Bennett,
C.
Whitney,
M.
Moore,
T.
Pilishvili,
K.
Dooling
(2013)
Use of 13‐Valent Pneumococcal Conjugate Vaccine and 23‐Valent Pneumococcal Polysaccharide Vaccine for Adults With Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
American Journal of Transplantation, 13
-
A.
Falsey,
Patricia
Hennessey,
M.
Formica,
C.
Cox,
E.
Walsh
(2005)
Respiratory syncytial virus infection in elderly and high-risk adults.
The New England journal of medicine, 352 17
-
D.
Shatz
(2005)
Vaccination considerations in the asplenic patient
Expert Review of Vaccines, 4
-
R.
Lazarus,
E.
Clutterbuck,
Ly-Mee
Yu,
J.
Bowman,
E.
Bateman,
L.
Diggle,
B.
Angus,
T.
Peto,
P.
Beverley,
D.
Mant,
A.
Pollard
(2011)
A randomized study comparing combined pneumococcal conjugate and polysaccharide vaccination schedules in adults.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 52 6
-
G.
Orthopoulos,
M.
Theodoridou,
V.
Ladis,
Dimitris
Tsousis,
V.
Spoulou
(2009)
The effect of 23-valent pneumococcal polysaccharide vaccine on immunological priming induced by 7-valent conjugate vaccine in asplenic subjects with beta-thalassemia.
Vaccine, 27 3
-
S.
Tomczyk,
N.
Bennett,
C.
Stoecker,
R.
Gierke,
M.
Moore,
C.
Whitney,
S.
Hadler,
T.
Pilishvili
(2014)
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Adults Aged ≥65 Years: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
Morbidity and Mortality Weekly Report, 63
-
D.
Musher,
Susan
Manof,
C.
Liss,
Richard
McFetridge,
Rocio
Marchese,
Bonnie
Bushnell,
F.
Alvarez,
Carla
Painter,
Michael
Blum,
J.
Silber
(2010)
Safety and antibody response, including antibody persistence for 5 years, after primary vaccination or revaccination with pneumococcal polysaccharide vaccine in middle-aged and older adults.
The Journal of infectious diseases, 201 4
-
(2009)
COPD Clinical Research Network
-
J.
Walters,
Sabin
Smith,
P.
Poole,
R.
Granger,
R.
Wood‐Baker
(2010)
Injectable vaccines for preventing pneumococcal infection in patients with chronic obstructive pulmonary disease.
The Cochrane database of systematic reviews, 11
-
S.
Romero-Steiner,
D.
Musher,
Marty
Cetron,
L.
Pais,
Jean
Groover,
A.
Fiore,
B.
Plikaytis,
G.
Carlone
(1999)
Reduction in functional antibody activity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 29 2
-
K.
Stein
(1992)
Thymus-independent and thymus-dependent responses to polysaccharide antigens.
The Journal of infectious diseases, 165 Suppl 1
-
D.
Musher,
S.
Manoff,
Richard
McFetridge,
C.
Liss,
Rocio
Marchese,
J.
Raab,
A.
Rueda,
Monica
Walker,
Patricia
Hoover
(2011)
Antibody persistence ten years after first and second doses of 23-valent pneumococcal polysaccharide vaccine, and immunogenicity and safety of second and third doses in older adults
Human Vaccines, 7
-
U.
Meltzer,
D.
Goldblatt
(2006)
Pneumococcal Polysaccharides Interact with Human Dendritic Cells
Infection and Immunity, 74
-
M.
Dransfield,
M.
Nahm,
M.
Han,
S.
Harnden,
G.
Criner,
F.
Martinez,
P.
Scanlon,
P.
Woodruff,
G.
Washko,
J.
Connett,
N.
Anthonisen,
W.
Bailey
(2009)
Superior immune response to protein-conjugate versus free pneumococcal polysaccharide vaccine in chronic obstructive pulmonary disease.
American journal of respiratory and critical care medicine, 180 6
-
E.
Shapiro,
J.
Clemens
(1984)
A controlled evaluation of the protective efficacy of pneumococcal vaccine for patients at high risk of serious pneumococcal infections.
Annals of internal medicine, 101 3
-
(2010)
Active Bacterial Core surveillance report, Emerging Infections Program Network, Streptococcus pneumoniae
-
B.
Hutchison,
A.
Oxman,
H.
Shannon,
S.
Lloyd,
C.
Altmayer,
K.
Thomas
(1999)
Clinical effectiveness of pneumococcal vaccine. Meta-analysis.
Canadian family physician Medecin de famille canadien, 45
-
J.
Puig-Barberà,
A.
Varea,
M.
Pinto,
M.
Benlliure
(2002)
Efectividad de la vacuna frente al neumococo en el anciano. Revisión sistemática y metaanálisis
Atencion Primaria, 30
-
M.
Fine,
Melanie
Smith,
C.
Carson,
F.
Meffe,
S.
Sankey,
L.
Weissfeld,
A.
Detsky,
W.
Kapoor
(1994)
Efficacy of pneumococcal vaccination in adults. A meta-analysis of randomized controlled trials.
Archives of internal medicine, 154 23
-
S.
Chaithongwongwatthana,
Waralak
Yamasmit,
S.
Limpongsanurak,
P.
Lumbiganon,
Joseph
DeSimone,
Jason
Baxter,
Jorge
Tolosa
(2006)
Pneumococcal vaccination during pregnancy for preventing infant infection.
The Cochrane database of systematic reviews, 1
-
D.
Fedson,
C.
Liss
(2004)
Precise answers to the wrong question: prospective clinical trials and the meta-analyses of pneumococcal vaccine in elderly and high-risk adults.
Vaccine, 22 8
-
M.
Seifert,
M.
Przekopowitz,
Sarah
Taudien,
Anna
Lollies,
Viola
Ronge,
Britta
Drees,
M.
Lindemann,
U.
Hillen,
Harald
Engler,
B.
Singer,
R.
Küppers
(2015)
Functional capacities of human IgM memory B cells in early inflammatory responses and secondary germinal center reactions
Proceedings of the National Academy of Sciences, 112
-
A.
Huss,
P.
Scott,
A.
Stuck,
C.
Trotter,
M.
Egger
(2009)
Efficacy of pneumococcal vaccination in adults: a meta-analysis
Canadian Medical Association Journal, 180
-
Eddie
Go,
Z.
Ballas
(1996)
Anti-pneumococcal antibody response in normal subjects: a meta-analysis.
The Journal of allergy and clinical immunology, 98 1
-
R.
Moore,
P.
Wiffen,
Benjamin
Lipsky
(2000)
Are the pneumococcal polysaccharide vaccines effective? Meta-analysis of the prospective trials
BMC Family Practice, 1
-
M.
Mufson,
M.
Mufson,
D.
Hughey,
Charles
Turner,
G.
Schiffman
(1991)
Revaccination with pneumococcal vaccine of elderly persons 6 years after primary vaccination.
Vaccine, 9 6
-
Elisabeth
Kugelberg
(2015)
B cell memory: Making sense in humans
Nature Reviews Immunology, 15
-
Catherine
Cornu,
D.
Yzebe,
P.
Léophonte,
J.
Gaillat,
J.
Boissel,
Michel
Cucherat
(2001)
Efficacy of pneumococcal polysaccharide vaccine in immunocompetent adults: a meta-analysis of randomized trials.
Vaccine, 19 32
-
A.
Melegaro,
W.
Edmunds
(2003)
The 23-Valent Pneumococcal Polysaccharide Vaccine. Part I. Efficacy of PPV in the Elderly: A Comparison of Meta-Analyses
European Journal of Epidemiology, 19
-
L.
Watson,
B.
Wilson,
N.
Waugh
(2002)
Pneumococcal polysaccharide vaccine: a systematic review of clinical effectiveness in adults.
Vaccine, 20 17-18
-
N.
Khardori
(2008)
Comparison of Pneumococcal Conjugate Polysaccharide and Free Polysaccharide Vaccines in Elderly Adults: Conjugate Vaccine Elicits Improved Antibacterial Immune Responses and Immunological Memory
Yearbook of Medicine, 2008
-
I.
Papadatou,
C.
Piperi,
K.
Alexandraki,
A.
Kattamis,
M.
Theodoridou,
V.
Spoulou
(2014)
Antigen-specific B-cell response to 13-valent pneumococcal conjugate vaccine in asplenic individuals with β-thalassemia previously immunized with 23-valent pneumococcal polysaccharide vaccine.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 59 6
-
J.
Puig-Barberá,
Á.
Varea,
M.
Pinto,
M.
Benlliure
(2002)
[Pneumococcal vaccine effectiveness in the elderly. Systematic review and meta-analysis].
Atencion primaria, 30 5
-
U.
Bauer
(2000)
[Centers for Disease Control and Prevention (CDC)].
Annales de dermatologie et de venereologie, 127 1
-
A.
Sheikh,
B.
Alves,
S.
Dhami
(2002)
Pneumococcal vaccine for asthma.
The Cochrane database of systematic reviews, 1
-
Miwako
Kobayashi,
N.
Bennett,
R.
Gierke,
O.
Almendares,
M.
Moore,
C.
Whitney,
T.
Pilishvili
(2015)
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).
MMWR. Morbidity and mortality weekly report, 64 34
-
N.
Bennett,
T.
Pilishvili,
C.
Whitney,
M.
Moore,
R.
Gierke,
A.
Harris
(2013)
Use of 13-Valent Pneumococcal Conjugate Vaccine and 23-Valent Pneumococcal Polysaccharide Vaccine Among Children Aged 6–18 Years with Immunocompromising Conditions: Recommendations of the Advisory Committee on Immunization Practices (ACIP)
MMWR. Morbidity and Mortality Weekly Report, 62
-
J.
Poolman,
R.
Borrow
(2011)
Hyporesponsiveness and its clinical implications after vaccination with polysaccharide or glycoconjugate vaccines
Expert Review of Vaccines, 10
-
D.
Musher,
A.
Rueda,
M.
Nahm,
E.
Graviss,
M.
Rodriguez‐Barradas
(2008)
Initial and subsequent response to pneumococcal polysaccharide and protein-conjugate vaccines administered sequentially to adults who have recovered from pneumococcal pneumonia.
The Journal of infectious diseases, 198 7
-
R.
Borrow,
D.
Goldblatt,
Nick
Andrews,
Peter
Richmond,
J.
Southern,
E.
Miller
(2001)
Influence of prior meningococcal C polysaccharide vaccination on the response and generation of memory after meningococcal C conjugate vaccination in young children.
The Journal of infectious diseases, 184 3
-
F.
Russell,
J.
Carapetis,
A.
Balloch,
P.
Licciardi,
A.
Jenney,
L.
Tikoduadua,
L.
Waqatakirewa,
J.
Pryor,
J.
Nelson,
G.
Byrnes,
Y.
Cheung,
M.
Tang,
M.
Tang,
E.
Mulholland,
E.
Mulholland
(2010)
Hyporesponsiveness to re-challenge dose following pneumococcal polysaccharide vaccine at 12 months of age, a randomized controlled trial.
Vaccine, 28 19
-
E
Davies,
Ceri
Hirst,
Richard
Lottenberg,
Nancy
Dower
(2004)
Pneumococcal vaccines for sickle cell disease.
The Cochrane database of systematic reviews, 1
-
(2012)
Vaccines Group; PENTA Steering Committee; Children’s HIV Association (CHIVA)
-
B.
Heyman
(2000)
Regulation of antibody responses via antibodies, complement, and Fc receptors.
Annual review of immunology, 18
-
M.
Straetemans,
Elisabeth
Sanders,
R.
Veenhoven,
A.
Schilder,
Roger
Damoiseaux,
Gerhard
Zielhuis
(2004)
Pneumococcal vaccines for preventing otitis media.
The Cochrane database of systematic reviews, 2
-
(2003)
Vaccine Safety Datalink
-
J.
Leech,
A.
Gervais,
F.
Ruben
(1987)
Efficacy of pneumococcal vaccine in severe chronic obstructive pulmonary disease.
CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 136 4
-
G.
Hanquet,
E.
Kissling,
A.
Fenoll,
R.
George,
A.
Lepoutre,
T.
Lernout,
D.
Tarragó,
E.
Varon,
J.
Verhaegen
(2010)
Pediatric Pneumococcal Serotypes in 4 European Countries
Emerging Infectious Diseases, 16
-
P.
Waight,
N.
Andrews,
S.
Ladhani,
C.
Sheppard,
M.
Slack,
E.
Miller
(2015)
Effect of the 13-valent pneumococcal conjugate vaccine on invasive pneumococcal disease in England and Wales 4 years after its introduction: an observational cohort study.
The Lancet. Infectious diseases, 15 5
-
R.
Borrow,
E.
Stanford,
P.
Waight,
M.
Helbert,
P.
Balmer,
R.
Warrington,
M.
Slack,
R.
George,
E.
Miller
(2008)
Serotype-Specific Immune Unresponsiveness to Pneumococcal Conjugate Vaccine following Invasive Pneumococcal Disease
Infection and Immunity, 76
-
N.
French,
N.
French,
J.
Nakiyingi,
L.
Carpenter,
L.
Carpenter,
E.
Lugada,
C.
Watera,
K.
Moi,
M.
Moore,
M.
Moore,
D.
Antvelink,
D.
Mulder,
E.
Janoff,
J.
Whitworth,
C.
Gilks
(2000)
23–valent pneumococcal polysaccharide vaccine in HIV-1-infected Ugandan adults: double-blind, randomised and placebo controlled trial
The Lancet, 355
-
J.
Goronzy,
C.
Weyand
(2013)
Understanding immunosenescence to improve responses to vaccines
Nature Immunology, 14
-
I.
Riley,
M.
Andrews,
R.
Howard,
P.
Tarr,
M.
Pfeiffer,
P.
Challands,
G.
Jennison,
R.
Douglas
(1977)
IMMUNISATION WITH A POLYVALENT PNEUMOCOCCAL VACCINE Reduction of Adult Respiratory Mortality in a New Guinea Highlands Community
The Lancet, 309
-
S.
Moberley,
J.
Holden,
D.
Tatham,
R.
Andrews
(2008)
Vaccines for preventing pneumococcal infection in adults.
The Cochrane database of systematic reviews, 1
-
S.
Conaty,
L.
Watson,
J.
Dinnes,
N.
Waugh
(2004)
The effectiveness of pneumococcal polysaccharide vaccines in adults: a systematic review of observational studies and comparison with results from randomised controlled trials.
Vaccine, 22 23-24
-
E.
Menson,
M.
Mellado,
A.
Bamford,
G.
Castelli,
D.
Duiculescu,
M.
Marczyńska,
M.
Navarro,
H.
Scherpbier,
P.
Heath
(2012)
Guidance on vaccination of HIV‐infected children in Europe
HIV Medicine, 13
-
M.
Reacher,
Anita
Shah,
D.
Livermore,
M.
Wale,
C.
Graham,
A.
Johnson,
H.
Heine,
M.
Monnickendam,
K.
Barker,
D.
James,
R.
George
(2000)
Bacteraemia and antibiotic resistance of its pathogens reported in England and Wales between 1990 and 1998: trend analysis
BMJ : British Medical Journal, 320
-
R.
Austrian,
Douglas
Rm,
G.
Schiffman,
Coetzee
Am,
Koornhof
Hj,
S.
Hayden-Smith,
Reid
Rd
(1976)
Prevention of pneumococcal pneumonia by vaccination.
Transactions of the Association of American Physicians, 89
-
C.
Gilks,
S.
Ojoo,
J.
Ojoo,
R.
Brindle,
J.
Paul,
B.
Batchelor,
J.
Kimari,
R.
Newnham,
J.
Bwayo,
F.
Plummer,
D.
Warrell
(1996)
Invasive pneumococcal disease in a cohort of predominantly HIV-1 infected female sex-workers in Nairobi, Kenya
The Lancet, 347
-
A.
Tomasz
(1995)
The pneumococcus at the gates.
The New England journal of medicine, 333 8
-
E.
Shapiro,
A.
Berg,
R.
Austrian,
Donna
Schroeder,
V.
Parcells,
Amy
Margolis,
Russell
Adair,
J.
Clemens
(1991)
The protective efficacy of polyvalent pneumococcal polysaccharide vaccine.
The New England journal of medicine, 325 21
-
S.
Sigurdardottir,
Kimberly
Center,
K.
Davidsdottir,
V.
Arason,
B.
Hjalmarsson,
Ragnheidur
Elisdottir,
Gunnhildur
Ingolfsdottir,
R.
Northington,
D.
Scott,
I.
Jónsdóttir
(2014)
Decreased immune response to pneumococcal conjugate vaccine after 23-valent pneumococcal polysaccharide vaccine in children.
Vaccine, 32 3
-
M.
Simberkoff,
A.
Cross,
M.
Al-Ibrahim,
A.
Baltch,
P.
Geiseler,
J.
Nadler,
A.
Richmond,
Raymond
Smith,
G.
Schiffman,
D.
Shepard,
J.
Eeckhout
(1986)
Efficacy of pneumococcal vaccine in high-risk patients. Results of a Veterans Administration Cooperative Study.
The New England journal of medicine, 315 21
-
Christina
Chang,
R.
Singleton,
P.
Morris,
A.
Chang
(2007)
Pneumococcal vaccines for children and adults with bronchiectasis.
The Cochrane database of systematic reviews, 2
-
K.
Kawakami,
Y.
Ohkusa,
R.
Kuroki,
Takeshi
Tanaka,
Kazuhiko
Koyama,
Yoshitaka
Harada,
Kouichi
Iwanaga,
T.
Yamaryo,
K.
Oishi
(2010)
Effectiveness of pneumococcal polysaccharide vaccine against pneumonia and cost analysis for the elderly who receive seasonal influenza vaccine in Japan.
Vaccine, 28 43
-
Á.
Domínguez,
L.
Salleras,
D.
Fedson,
C.
Izquierdo,
L.
Ruíz,
P.
Ciruela,
A.
Fenoll,
J.
Casal
(2005)
Effectiveness of pneumococcal vaccination for elderly people in Catalonia, Spain: a case-control study.
Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 40 9
-
Á.
Domínguez,
C.
Izquierdo,
L.
Salleras,
L.
Ruíz,
D.
Sousa,
J.
Bayas,
M.
Nebot,
W.
Varona,
J.
Celorrio,
J.
Carratalá
(2010)
Effectiveness of the pneumococcal polysaccharide vaccine in preventing pneumonia in the elderly
European Respiratory Journal, 36
-
J.
Davies,
M.
Lewis,
J.
Wimperis,
I.
Rafi,
S.
Ladhani,
P.
Bolton-Maggs
(2011)
Review of guidelines for the prevention and treatment of infection in patients with an absent or dysfunctional spleen: Prepared on behalf of the British Committee for Standards in Haematology by a Working Party of the Haemato‐Oncology Task Force
British Journal of Haematology, 155
-
Takaya
Maruyama,
O.
Taguchi,
M.
Niederman,
J.
Morser,
Hiroyasu
Kobayashi,
Tetsu
Kobayashi,
C.
D'Alessandro-Gabazza,
Sei
Nakayama,
K.
Nishikubo,
T.
Noguchi,
Y.
Takei,
E.
Gabazza
(2010)
Efficacy of 23-valent pneumococcal vaccine in preventing pneumonia and improving survival in nursing home residents: double blind, randomised and placebo controlled trial
The BMJ, 340
-
A.
Davis,
C.
Aranda,
C.
Aranda,
G.
Schiffman,
G.
Schiffman,
Lynn
Christianson,
Lynn
Christianson
(1987)
Pneumococcal infection and immunologic response to pneumococcal vaccine in chronic obstructive pulmonary disease. A pilot study.
Chest, 92 2
-
(2010)
Working Group for the Study of Prevention of CAP in the Elderly
-
J.
Butler
(2004)
Epidemiology of Pneumococcal Disease
-
Stefania
Bjarnarson,
H.
Benonisson,
G.
Giudice,
I.
Jónsdóttir
(2013)
Pneumococcal Polysaccharide Abrogates Conjugate-Induced Germinal Center Reaction and Depletes Antibody Secreting Cell Pool, Causing Hyporesponsiveness
PLoS ONE, 8
-
A.
Benin,
K.
O'Brien,
J.
Watt,
R.
Reid,
E.
Zell,
Scott
Katz,
C.
Donaldson,
A.
Parkinson,
A.
Schuchat,
M.
Santosham,
C.
Whitney
(2003)
Effectiveness of the 23-valent polysaccharide vaccine against invasive pneumococcal disease in Navajo adults.
The Journal of infectious diseases, 188 1
-
A.
Furumoto,
Y.
Ohkusa,
Meng
Chen,
K.
Kawakami,
H.
Masaki,
Y.
Sueyasu,
T.
Iwanaga,
H.
Aizawa,
T.
Nagatake,
K.
Oishi
(2008)
Additive effect of pneumococcal vaccine and influenza vaccine on acute exacerbation in patients with chronic lung disease.
Vaccine, 26 33
-
I.
Alfageme,
R.
Vázquez,
N.
Reyes,
J.
Muñoz,
Ana
Fernández,
M.
Hernandez,
M.
Meriño,
J.
Pérez,
J.
Lima
(2005)
Clinical efficacy of anti-pneumococcal vaccination in patients with COPD
Thorax, 61
-
I.
Papadatou,
G.
Orthopoulos,
M.
Theodoridou,
V.
Spoulou
(2015)
Long-lasting hyporesponsivenss induced by the 23-valent pneumococcal polysaccharide vaccine (PPV23) in asplenic patients with β-thalassemia major.
Vaccine, 33 32
-
D.
Granoff,
Rajesh
Gupta,
R.
Belshe,
E.
Anderson
(1998)
Induction of immunologic refractoriness in adults by meningococcal C polysaccharide vaccination.
The Journal of infectious diseases, 178 3
-
E.
Clutterbuck,
R.
Lazarus,
Ly-Mee
Yu,
J.
Bowman,
E.
Bateman,
L.
Diggle,
B.
Angus,
T.
Peto,
P.
Beverley,
D.
Mant,
A.
Pollard
(2012)
Pneumococcal Conjugate and Plain Polysaccharide Vaccines Have Divergent Effects on Antigen-Specific B Cells
The Journal of Infectious Diseases, 205
-
K.
Pape,
Justin
Taylor,
R.
Maul,
P.
Gearhart,
M.
Jenkins
(2011)
Different B Cell Populations Mediate Early and Late Memory During an Endogenous Immune Response
Science, 331
-
L.
Jackson,
K.
Neuzil,
Onchee
Yu,
P.
Benson,
W.
Barlow,
A.
Adams,
Christi
Hanson,
Lisa
Mahoney,
D.
Shay,
W.
Thompson
(2003)
Effectiveness of pneumococcal polysaccharide vaccine in older adults.
The New England journal of medicine, 348 18
-
R.
Dagan,
N.
Givon‐Lavi,
D.
Greenberg,
B.
Fritzell,
C.
Siegrist
(2010)
Nasopharyngeal carriage of Streptococcus pneumoniae shortly before vaccination with a pneumococcal conjugate vaccine causes serotype-specific hyporesponsiveness in early infancy.
The Journal of infectious diseases, 201 10